Larval therapy: a novel treatment in eliminating methicillin-resistant Staphylococcus aureus from diabetic foot ulcers.
Bowling
Frank L
FL
University Department of Medicine and Diabetes, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, U.K. frank.bowling@manchester.ac.uk
Salgami
Eleanna V
EV
Boulton
Andrew J M
AJ
D000081:Acetamides / Q000627:therapeutic use; D000368:Aged; D000818:Animals; D017719:Diabetic Foot / Q000188:drug therapy / Q000382:microbiology* / Q000628:therapy*; D003929:Diabetic Neuropathies / Q000503:physiopathology; D016523:Foot Ulcer / Q000382:microbiology / Q000628:therapy*; D006801:Humans; D007814:Larva; D000069349:Linezolid; D016106:Methicillin Resistance; D008875:Middle Aged; D023303:Oxazolidinones / Q000627:therapeutic use; D018579:Patient Selection; D015203:Reproducibility of Results; D013211:Staphylococcus aureus / Q000187:drug effects / Q000302:isolation & purification*; D014640:Vancomycin / Q000627:therapeutic use
D000081:Acetamides; D023303:Oxazolidinones; D014640:Vancomycin; D000069349:Linezolid